ALKS - Latest News

Alkermes plc (ALKS), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $6.49B. Trailing twelve-month P/E ratio is 42.34. Beta to the broader market is 0.26.

The article list below shows the most recent ALKS headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent ALKS Headlines

Alkermes Gains Momentum After Sleep Disorder Trial Clears Key Hurdles

benzinga.com - May 12, 2026

Alkermes Inc. plc (NASDAQ:ALKS) stock is trading higher on Tuesday following the announcement of positive topline results from the REVITALYZ phase 3

Alkermes Announces Positive Topline Results From REVITALYZ℠ Phase 3 Study Evaluating LUMRYZ® (sodium oxybate) Extended-Release in Adults With Idiopathic Hypersomnia

businesswire.com - May 12, 2026

DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) today announced positive topline results from the REVITALYZ℠ double-blind, placebo-controlled, ra

Alkermes Analysts Increase Their Forecasts Following Strong Q1 Results

benzinga.com - May 6, 2026

Alkermes (NASDAQ:ALKS) reported upbeat results for the first quarter on Tuesday.

Alkermes' Q1 Earnings & Revenues Beat Estimates, Stock Rises

zacks.com - May 6, 2026

ALKS beats Q1 estimates as strong proprietary drug sales lift revenues by 28%, sending shares higher, while Lumryz adds a fresh growth driver.

Alkermes: A Sleep Medicine Platform Hidden Inside A Mature CNS Company

seekingalpha.com - May 6, 2026

Alkermes is transitioning into an integrated neuroscience and sleep medicine company, highlighted by the Avadel acquisition and LUMRYZ integration. Q

How News Affects ALKS Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track ALKS's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked ALKS news questions

What is the latest ALKS news headline?

The most recent ALKS headline (May 12, 2026) is "Alkermes Gains Momentum After Sleep Disorder Trial Clears Key Hurdles". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the ALKS news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What ALKS news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual ALKS options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.